ArticleCurrent cancer drug targets2024

Hybrid Nanoparticle for Co-delivering Paclitaxel and Dihydroartemisinin to Exhibit Synergic Anticancer Therapeutics.

Bao Ngoc Tran et al.PubMed ↗Publisher ↗

No numbers read from the abstract.